Cargando…

Covid-19 apps, Corona vaccination apps and data “ownership”

Already before the present Covid-19 health crisis an emerging trend could be seen towards offering health services from a distance, called “e-health”. This trend, like so many other developments towards digitalisation of our societies, received a considerable impetus because of the Covid-19 crisis....

Descripción completa

Detalles Bibliográficos
Autor principal: van Erp, Sjef
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9684816/
http://dx.doi.org/10.1007/s12689-022-00097-7
_version_ 1784835372975390720
author van Erp, Sjef
author_facet van Erp, Sjef
author_sort van Erp, Sjef
collection PubMed
description Already before the present Covid-19 health crisis an emerging trend could be seen towards offering health services from a distance, called “e-health”. This trend, like so many other developments towards digitalisation of our societies, received a considerable impetus because of the Covid-19 crisis. First, the rise of Covid-19 tracing (and/or tracking) apps and now to be followed by the advance of Corona vaccination apps has made us aware of the benefits which e-health may bring, particularly in a situation where distance means safety. The apps contain very personal information and, consequently, have provoked questions as to whether the apps sufficiently protect a person’s right to privacy and data protection as safeguarded by the EU’s General Data Protection Regulation. The nature of the data, however, is such that also questions as to the importance of access by public health authorities in the public interest can be asked. Also, although commercial, but still important for developing and producing vaccines, for the pharmaceutical industry the data are important. The result is a conflict particularly between entitlement to privacy protection and the general interest, causing questions to be asked about which interest has priority. It might very well be, however, that this question, asked as such, is beside the point. Given that data are non-rivalrous and non-depletable, because they can be copied and copied, questions about which entitlement has priority cannot be answered in absolute terms. Rights regarding data depend upon who at a particular time has control over the data, who else has control and what control between all those involved then means. Looking at who has which right to data one can see an entitlement paradigm surfacing which is multi-perspective, relative and dynamic. Calling data entitlement “ownership” is not a reference to ownership in the traditional sense of the word, but to management. To decide what management in a particular situation means interest balancing exercises must be made. These exercises will change over time, as accordingly will the answer to the question who is “owner” of data in Covid-19 and Corona vaccination apps.
format Online
Article
Text
id pubmed-9684816
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-96848162022-11-28 Covid-19 apps, Corona vaccination apps and data “ownership” van Erp, Sjef China-EU Law J Article Already before the present Covid-19 health crisis an emerging trend could be seen towards offering health services from a distance, called “e-health”. This trend, like so many other developments towards digitalisation of our societies, received a considerable impetus because of the Covid-19 crisis. First, the rise of Covid-19 tracing (and/or tracking) apps and now to be followed by the advance of Corona vaccination apps has made us aware of the benefits which e-health may bring, particularly in a situation where distance means safety. The apps contain very personal information and, consequently, have provoked questions as to whether the apps sufficiently protect a person’s right to privacy and data protection as safeguarded by the EU’s General Data Protection Regulation. The nature of the data, however, is such that also questions as to the importance of access by public health authorities in the public interest can be asked. Also, although commercial, but still important for developing and producing vaccines, for the pharmaceutical industry the data are important. The result is a conflict particularly between entitlement to privacy protection and the general interest, causing questions to be asked about which interest has priority. It might very well be, however, that this question, asked as such, is beside the point. Given that data are non-rivalrous and non-depletable, because they can be copied and copied, questions about which entitlement has priority cannot be answered in absolute terms. Rights regarding data depend upon who at a particular time has control over the data, who else has control and what control between all those involved then means. Looking at who has which right to data one can see an entitlement paradigm surfacing which is multi-perspective, relative and dynamic. Calling data entitlement “ownership” is not a reference to ownership in the traditional sense of the word, but to management. To decide what management in a particular situation means interest balancing exercises must be made. These exercises will change over time, as accordingly will the answer to the question who is “owner” of data in Covid-19 and Corona vaccination apps. Springer Berlin Heidelberg 2022-11-23 2022 /pmc/articles/PMC9684816/ http://dx.doi.org/10.1007/s12689-022-00097-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
van Erp, Sjef
Covid-19 apps, Corona vaccination apps and data “ownership”
title Covid-19 apps, Corona vaccination apps and data “ownership”
title_full Covid-19 apps, Corona vaccination apps and data “ownership”
title_fullStr Covid-19 apps, Corona vaccination apps and data “ownership”
title_full_unstemmed Covid-19 apps, Corona vaccination apps and data “ownership”
title_short Covid-19 apps, Corona vaccination apps and data “ownership”
title_sort covid-19 apps, corona vaccination apps and data “ownership”
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9684816/
http://dx.doi.org/10.1007/s12689-022-00097-7
work_keys_str_mv AT vanerpsjef covid19appscoronavaccinationappsanddataownership